Following Through On Prior Plan, Genzyme Sells Off Genetic Testing Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
Sale of Genzyme Genetics for $925 million to LabCorp seen as enhancing the biotech's potential purchase value.